Hemodynamic Effects of Controlled‐Release Nifedipine for Tocolysis in Normotensive Pregnant Women
Journal of Obstetrics and Gynaecology Research · 2026-11 · 52 (11)
DOI: 10.1111/jog.70560 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 10.11.2026. Verfasst von Takafumi Ushida und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Nifedipine, Tocolytic Agents, Tocolysis, Blood Pressure. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Aim
Nifedipine is widely used as a tocolytic agent for threatened preterm labor. However, its hemodynamic effects in normotensive pregnant women, particularly when administered as a controlled‐release formulation, remain unclear. We evaluated changes in maternal hemodynamics and adverse effects after controlled‐release nifedipine administration in normotensive pregnant women with threatened preterm labor.
Methods
This retrospective observational study included normotensive women with singleton pregnancies who received controlled‐release nifedipine as maintenance therapy for threatened preterm labor between 2018 and 2025. Maternal blood pressure, heart rate, respiratory rate, hypotension (systolic blood pressure < 90 mmHg or diastolic blood pressure < 60 mmHg), tachycardia (≥ 120 beats/min), and adverse maternal and fetal effects were evaluated before and after nifedipine administration.
Results
Overall, 38 women were included in the final analyses. Systolic blood pressure significantly decreased from 110.2 ± 9.1 mmHg to 107.5 ± 10.2 mmHg after administration (mean change, −2.7 mmHg; 95% confidence interval, −4.5 to −0.8; p < 0.01). Diastolic blood pressure did not change significantly (−0.7 mmHg; −2.2 to 0.8 mmHg; p = 0.35). Heart rate significantly decreased from 95.3 ± 14.5 to 90.9 ± 12.4 beats/min. The incidence of hypotension and tachycardia did not differ significantly after nifedipine administration. No emergency deliveries were attributed to maternal hypotension. Headache was the most commonly reported adverse effect (28.9%).
Conclusions
Controlled‐release nifedipine was associated with a small decrease in systolic blood pressure without serious maternal or fetal adverse events. With appropriate monitoring, controlled‐release nifedipine may be a feasible option for maintenance or adjunctive tocolytic therapy in normotensive pregnant women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Division of Reproduction and Perinatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Japan.
ORCID-Profile: Takafumi Ushida, Yoshitaka Shiraishi, Kazuya Fuma, Sho Tano, Seiko Matsuo
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Ushida, T., Fujito, S., Shiraishi, Y., Nozaki, Y., Fuma, K., Tano, S., Matsuo, S., & Kajiyama, H. (2026). Hemodynamic Effects of Controlled‐Release Nifedipine for Tocolysis in Normotensive Pregnant Women. Journal of Obstetrics and Gynaecology Research, 52(11). https://doi.org/10.1111/jog.70560
Vancouver
Ushida T, Fujito S, Shiraishi Y, Nozaki Y, Fuma K, Tano S, et al. Hemodynamic Effects of Controlled‐Release Nifedipine for Tocolysis in Normotensive Pregnant Women. Journal of Obstetrics and Gynaecology Research. 2026;52(11). doi:10.1111/jog.70560
BibTeX
@article{Ushida2026,
author = {Ushida, Takafumi and Fujito, Sumire and Shiraishi, Yoshitaka and Nozaki, Yuki and Fuma, Kazuya and Tano, Sho and Matsuo, Seiko and Kajiyama, Hiroaki},
title = {Hemodynamic Effects of Controlled‐Release Nifedipine for Tocolysis in Normotensive Pregnant Women},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2026},
volume = {52},
number = {11},
doi = {10.1111/jog.70560}
}
EUVIMED